Icelandic Salmon AS (ICE:ISLAX)
Iceland · Delayed Price · Currency is ISK | Market Cap | 33.18B -19.7% |
| Revenue (ttm) | 12.67B -12.5% |
| Net Income | -3.65B |
| EPS | -117.97 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Average Volume | 3,337 |
| Open | 1,080.00 |
| Previous Close | 1,070.00 |
| Day's Range | 1,080.00 - 1,080.00 |
| 52-Week Range | 802.00 - 1,300.00 |
| Beta | -0.22 |
| RSI | 61.37 |
| Earnings Date | May 20, 2026 |
About Icelandic Salmon AS
Icelandic Salmon AS, together with its subsidiaries, engages in production, processing, and sale of salmon and salmon-based products in Europe, North America, and Asia. It is involved in the salmon farming activities. The company was founded in 2001 and is headquartered in Kverva, Norway. Icelandic Salmon AS operates as a subsidiary of SalMar ASA. [Read more]
Financial Performance
In 2025, Icelandic Salmon AS's revenue was 86.10 million, a decrease of -12.51% compared to the previous year's 98.42 million. Losses were -24.81 million, 703.5% more than in 2024.
Financial numbers in EUR Financial StatementsNews
Icelandic Salmon AS (STU:I6X) Q4 2025 Earnings Call Highlights: Navigating Challenges and ...
Icelandic Salmon AS (STU:I6X) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities
Q4 2025 Icelandic Salmon AS Earnings Call Transcript
Q4 2025 Icelandic Salmon AS Earnings Call Transcript
Icelandic Salmon AS Earnings Call Transcript: Q4 2025
Q4 2025 saw strong biological and financial progress, with higher biomass, improved equity, and a positive tax ruling. 2026 guidance targets a 67% volume increase, with CapEx focused on maintenance and expectations for stronger market prices in Q2.
Icelandic Salmon AS (OISE:ISLAX) Q3 2025 Earnings Call Highlights: Navigating Challenges with ...
Icelandic Salmon AS (OISE:ISLAX) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth
Q3 2025 Icelandic Salmon AS Earnings Call Transcript
Q3 2025 Icelandic Salmon AS Earnings Call Transcript
Icelandic Salmon AS Earnings Call Transcript: Q3 2025
High production costs and a one-time biomass adjustment led to a negative EBIT, despite increased harvest volumes and strong price achievement in key markets. Bank loan terms were extended, and volume guidance remains robust for 2025 and 2026.
Q2 2025 Icelandic Salmon AS Earnings Call Transcript
Q2 2025 Icelandic Salmon AS Earnings Call Transcript
Icelandic Salmon AS Earnings Call Transcript: Q2 2025
Q2 results were impacted by a BKD outbreak, leading to higher costs and early harvest, with operational EBIT at €8.3 million and negative €2.1 per kilo. Volume guidance for 2024 was lowered, but significant biomass growth is expected in 2025, supporting future volume increases.
Icelandic Salmon AS Earnings Call Transcript: Q1 2025
Q1 2025 saw a sharp drop in harvest volume and negative EBITDA due to biological challenges and low capacity utilization. Investments continued in production capacity, with 2025 guidance maintained at 15,000 tons and expectations for lower costs and higher volumes in the second half.
Icelandic Salmon AS (FRA:I6X) Q4 2024 Earnings Call Highlights: Record Harvests and Strategic ...
Icelandic Salmon AS (FRA:I6X) Q4 2024 Earnings Call Highlights: Record Harvests and Strategic Financing Amidst Biological Challenges
Q4 2024 Icelandic Salmon AS Earnings Call Transcript
Q4 2024 Icelandic Salmon AS Earnings Call Transcript
Icelandic Salmon AS Earnings Call Transcript: Q4 2024
Q4 featured increased harvest volumes, stable biology, and strong market prices, though full-year harvest declined due to earlier biological challenges. 2025 guidance remains at 15,000 tons, with lower costs expected as volumes recover and new smolt facility capacity comes online.
Icelandic Salmon AS Earnings Call Transcript: Q3 2024
Q3 2024 saw stabilized operations and improved biological control, but harvest volumes and EBIT remained low due to earlier challenges. Strong demand in North America and Asia boosted sales mix, and volumes are expected to rise significantly in Q4.
Icelandic Salmon AS Earnings Call Transcript: Q2 2024
Q2 results were heavily impacted by biological challenges, leading to negative EBIT and reduced harvest volumes, but operational improvements and new licenses position the company for higher output in H2 2024. Demand remains strong, and cost reductions are expected as capacity utilization improves.